Statins:: lower lipids and better bones?

被引：46

作者：

Rogers, MJ ^{[1
]}

机构：

[1] Univ Aberdeen, Sch Med, Dept Med & Therapeut, Bone Res Grp, Aberdeen AB25 2ZD, Scotland

来源：

NATURE MEDICINE | 2000年 / 6卷 / 01期

关键词：

D O I：

10.1038/71484

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Although statins are widely used as cholesterol-lowering drugs, a recent study suggests that these compounds have anabolic effects on bone and could be developed into new treatments for common metabolic bone diseases such as osteoporosis.

引用

页码：21 / 23

页数：3

共 10 条

[1] MEVINOLIN - A HIGHLY POTENT COMPETITIVE INHIBITOR OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE AND A CHOLESTEROL-LOWERING AGENT [J].

ALBERTS, AW ;

CHEN, J ;

KURON, G ;

HUNT, V ;

HUFF, J ;

HOFFMAN, C ;

ROTHROCK, J ;

LOPEZ, M ;

JOSHUA, H ;

HARRIS, E ;

PATCHETT, A ;

MONAGHAN, R ;

CURRIE, S ;

STAPLEY, E ;

ALBERSSCHONBERG, G ;

HENSENS, O ;

HIRSHFIELD, J ;

HOOGSTEEN, K ;

LIESCH, J ;

SPRINGER, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07) :3957-3961

[2]

Bauer DC, 1999, J BONE MINER RES, V14, pS179

[3] Alendronate mechanism of action:: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro [J].

Fisher, JE ;

Rogers, MJ ;

Halasy, JM ;

Luckman, SP ;

Hughes, DE ;

Masarachia, PJ ;

Wesolowski, G ;

Russell, RGG ;

Rodan, GA ;

Reszka, AA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) :133-138

[4]

Garrett IR, 1999, J BONE MINER RES, V14, pS525

[5] Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors [J].

Hamelin, BA ;

Turgeon, J .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (01) :26-37

[6] Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras [J].

Luckman, SP ;

Hughes, DE ;

Coxon, FP ;

Russell, RGG ;

Rogers, MJ .

JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (04) :581-589

[7] Stimulation of bone formation in vitro and in rodents by statins [J].

Mundy, G ;

Garrett, R ;

Harris, S ;

Chan, J ;

Chen, D ;

Rossini, G ;

Boyce, B ;

Zhao, M ;

Gutierrez, G .

SCIENCE, 1999, 286 (5446) :1946-1949

[8] Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin [J].

Plotkin, LI ;

Weinstein, RS ;

Parfitt, AM ;

Roberson, PK ;

Manolagas, SC ;

Bellido, T .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (10) :1363-1374

[9] Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates [J].

van Beek, E ;

Pieterman, E ;

Cohen, L ;

Löwik, C ;

Papapoulos, S .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 264 (01) :108-111

[10] Protein prenylation: Molecular mechanisms and functional consequences [J].

Zhang, FL ;

Casey, PJ .

ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 :241-269

← 1 →